ClinConnect ClinConnect Logo
Search / Trial NCT07042451

An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

Launched by LOYOLA MARYMOUNT UNIVERSITY · Jun 20, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a smartphone app called Pink Cloud, designed to help people recovering from substance or alcohol use problems. The app offers access to thousands of in-person and online 12-Step meetings, along with helpful tools like a sobriety tracker, daily planner, and personal reflection exercises. The goal is to see if using this app can help people stay sober longer, reduce problems related to substance use, and encourage more involvement in recovery activities and support groups.

People who are 18 or older, live in the United States, own a smartphone, and are comfortable reading English might be eligible to join. Participants should have used alcohol or drugs in the past (but not in the last few days), be willing to attend a 12-Step or peer support meeting soon, and not currently be in formal treatment or planning to start treatment within the next month. If chosen, participants will be randomly given access to the Pink Cloud app or placed in a control group, and they will be asked to complete follow-up surveys after 1, 3, and 6 months. This study aims to find out whether the app can provide helpful support for people working to maintain their recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participant is 18 years of age or older
  • Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  • Participant owns a personal smartphone with cellular service
  • Participant is a permanent resident of the United States
  • Participant feels comfortable reading and understanding written English in everyday situations
  • Participant has consumed alcohol and/or used drugs (excluding tobacco or prescribed medication) at some point in their life, but not within the past couple of days
  • Participant is not currently attending outpatient or residential treatment for substance and/or alcohol use
  • Participant does not have a plan to enter substance and/or alcohol treatment in the next 30 days
  • Participant has been invited by the research team to either the intervention or control condition and redeemed their subscription code.
  • Informed consent is provided
  • Exclusion Criteria:
  • Participant is younger than 18 years of age
  • Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  • Participant does not own a personal smartphone with cellular service
  • Participant is not a permanent resident of the United States
  • Participant does not feel comfortable reading and understanding written English in everyday situations
  • Participant has consumed alcohol or used drugs (excluding tobacco or prescribed medication) within the past couple of days
  • Participant has never consumed alcohol or used drugs
  • Participant is currently attending outpatient or residential treatment for substance and/or alcohol use
  • Participant has a plan to enter substance and/or alcohol treatment in the next 30 days
  • Participant was not invited by the research team or did not redeem their assigned subscription code
  • Informed consent is not provided

About Loyola Marymount University

Loyola Marymount University (LMU) is a distinguished institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, LMU leverages its academic resources and expertise to conduct innovative studies aimed at improving patient outcomes and enhancing medical knowledge. The university fosters a collaborative environment, engaging faculty, students, and healthcare professionals in rigorous scientific inquiry while adhering to ethical standards and regulatory compliance. Through its commitment to excellence and community engagement, LMU aims to contribute significantly to the advancement of clinical research and the betterment of public health.

Locations

Los Angeles, California, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported